Doubtful use of placebo following placebo in recent controlled trials of lasmiditan and ubrogepant for the treatment of migraine attacks-论文-万方医学网

Doubtful use of placebo following placebo in recent controlled trials of lasmiditan and ubrogepant for the treatment of migraine attacks

导出原文传递

翻译打印收藏纠错

作者： Peer Tfelt-Hansen ^[1] ; Karsten J?rgensen ^[2] ; Hans-Christoph Diener ^[3]

作者单位： Danish Headache Center, Department of Neurology, Rigshospitalet -Glostrup, Faculty of Health and ^[1] Centre for Evidence-Based Medicine Odense (CEBMO) and Cochrane Denmark, Department of Clinical ^[2] Institute Medical Informatics, Biometry and Epidemiology, Medical Faculty of the University ^[3]

关键词 Placebo ubrogepant lasmiditan

发布时间 2022-07-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Doubtful use of placebo following placebo in recent controlled trials of lasmiditan and ubrogepant for the treatment of migraine attacks

相似文献

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Doubtful use of placebo following placebo in recent controlled trials of lasmiditan and ubrogepant for the treatment of migraine attacks

相似文献

相关期刊

检索历史清除